MedTrace Logo

Systematic Description of the Post EMR Defect

NCT03117400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 482

Last updated 2023-06-29

No results posted yet for this study

Summary

To date there are no available data on the utility of the endoscopic mucosal resection (EMR) defect in stratifying the risk of immediate or delayed adverse outcomes, particularly clinically significant post EMR bleeding (CSPEB).

The investigators aimed to analyse the data to determine if any of these EMR defect features allow us to estimate the risk of CSPEB. This will help endoscopists to identify defects with a high risk of adverse outcomes and may translate into improved patient outcomes.

Conditions

  • Delayed Bleeding Post EMR
  • Large Laterally Spreading Lesion in the Colon
  • Endoscopic Mucosal Resection

Sponsors & Collaborators

  • Western Sydney Local Health District

    lead OTHER

Principal Investigators

  • Michael Bourke, MBBS, FRACP · WSLHD

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-02
Primary Completion
2016-11-30
Completion
2017-03-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03117400 on ClinicalTrials.gov